<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01133730</url>
  </required_header>
  <id_info>
    <org_study_id>10-0200-A</org_study_id>
    <nct_id>NCT01133730</nct_id>
  </id_info>
  <brief_title>Transversalis Fascial Plane Nerve Block in Iliac Crest Bone Graft</brief_title>
  <official_title>The Analgesic Efficacy of the Transversalis Fascia Plane Block in Iliac Crest Bone Graft Harvesting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hand or wrist surgery often requires the use of bony material in order to accomplish any
      associated reconstructive aspects required for the surgery. The iliac crest is often used as
      the source of bone for such surgery and harvesting from this site is performed simultaneously
      with the hand/wrist surgery. In terms of anesthesia, patients typically receive a
      supraclavicular nerve block for the hand/wrist surgery, and a general anesthestic for the
      bone graft, though spinal block may also be performed. This study will look at the use of a
      transversalis fascia plane (TFP) nerve block (ie, to numb the nerves going to the iliac
      crest) in combination with a general anesthetic to see if post-operative pain and opioid
      consumption is reduced using the TFP block.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2010</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>Opioid consumption in the first 24 hours following ICBG. This will be expressed in terms of milligrams doses of IV morphine. Where other opioids are used, the doses will be converted to the equivalent IV morphine dose using standard opioid dosage conversion tables.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>7 days</time_frame>
    <description>Opioid consumption (expressed as milligram doses of IV morphine) in the following phases
Intraoperative phase (from start of surgery to end of surgery)
Postoperative care unit stay (from admission to discharge)
First 48 hours following ICBG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain measures</measure>
    <time_frame>48 hours</time_frame>
    <description>Pain scores at the ICBG site, measured using a visual analogue scale (VAS) (scale 0-10) and starting in recovery, then every 4 hrs for the next 48 hrs.
Pain at the primary surgical site (VAS 0-10)
Duration of block, defined as the time from completion of block performance to the time of onset of increased pain at the ICBG harvest site (as perceived by the patient)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time of block performance</measure>
    <time_frame>6 hours</time_frame>
    <description>Time required to perform the TFP block (defined as the time between placement of the ultrasound probe on the patient, and withdrawal of the block needle)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>12 months</time_frame>
    <description>TFP block complications and adverse events (e.g. vascular puncture, intravascular local anesthetic injection and local hematoma)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Upper Limb Surgery</condition>
  <condition>Iliac Crest Bone Harvest</condition>
  <arm_group>
    <arm_group_label>Active treatment group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound-guided TFP block with 20ml 0.5% ropivacaine + 1:200 000 epinephrine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo arm</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Ultrasound-guided TFP block with 20ml of 5% dextrose solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Active treatment</intervention_name>
    <description>US-guided TFP block with 20ml 0.5% ropivacaine + 1:200 000 epinephrine</description>
    <arm_group_label>Active treatment group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Arm</intervention_name>
    <description>US-guided TFP block with 20ml of 5% dextrose solution</description>
    <arm_group_label>Placebo arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. ASA physical status I-III

          2. 18-85 years of age, inclusive

          3. Weight 50kg+

          4. Scheduled for elective upper limb surgery, which can be solely performed under a
             brachial plexus block, and requiring an ICBG

        Exclusion Criteria:

          1. Contraindications to regional blockade (e.g., allergy to local anesthetics,
             coagulopathy, malignancy or infection in the area)

          2. Pregnancy

          3. History of alcohol or drug dependency/abuse

          4. History of long term opioid intake or chronic pain disorder

          5. History of significant psychiatric conditions that may affect patient assessment

          6. Failure of upper extremity block

          7. Previous iliac crest bone grafting

          8. History of severe pelvic and hip conditions that could interfere with the long-term
             functional assessments of the study

          9. Inability to understand the informed consent and demands of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2010</study_first_submitted>
  <study_first_submitted_qc>May 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 31, 2010</study_first_posted>
  <last_update_submitted>December 13, 2017</last_update_submitted>
  <last_update_submitted_qc>December 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 15, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>supraclavicular nerve block</keyword>
  <keyword>regional anesthesia</keyword>
  <keyword>transversalis fascia plane block</keyword>
  <keyword>ultrasound guided</keyword>
  <keyword>opioid consumption</keyword>
  <keyword>iliac crest bone harvest</keyword>
  <keyword>hand surgery</keyword>
  <keyword>wrist surgery</keyword>
  <keyword>Upper limb surgery combined with iliac crest bone harvest.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>CREST Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

